Vaultly tag

Sofinnova Partners news and market signals

Public Vaultly articles where Sofinnova Partners appears among the affected assets. Premium market intelligence becomes searchable here after 24 hours.

Bionyra Pharma Secures, 143 Million to Scale Inflammatory Disease Biologics

StartupsBasic

Medium 8/10Sanofi Jeito Capital

Bionyra Pharma Secures, 143 Million to Scale Inflammatory Disease Biologics

Paris and Boston-based Bionyra Pharma has officially launched with a significant, 143 million Series A funding round. The capital injection aims to accelerate the development of next-generation biologics targeting immune-mediated inflammatory conditions.

June 22, 2026Published 2 hours ago